C3 is pleased to share that a research grant has been awarded to Drs. Ana Töpf, Jordi Diaz-Manera, and Volker Straub at the John Walton Muscular Dystrophy Research Centre at Newcastle University. This project, titled “Understanding the variable expression of dominant calpainopathies,” explores the molecular basis for LGMDD4, also known as dominant calpainopathy. The Challenges…
Coalition to Cure Calpain 3
C3 has a pinpoint focus to drive research toward a treatment or cure for calpainopathy (LGMD2A/R1 and LGMDD4)
Explore Our Mission
Understanding Calpainopathy
Understanding Calpainopathy
Learn more about LGMD2A/R1 and LGMDD4, how these types of limb-girdle muscular dystrophy are diagnosed and inherited, and how you can take part in advancing research
Learn More
Advancing the Science
Advancing the Science
Explore the projects we fund, our grant program, and the toolbox we’re building to speed research and clinical trials in LGMD2A/R1 and LGMDD4
Explore Research
Fueling Treatments
Fueling Treatments
Your support helps us make a big impact, even with small investments. Discover how you can get involved and help fuel treatments and a cure for calpainopathy (LGMD2A/R1 and LGMDD4).
Get Involved